Dr. Schultzs focus in her current position is to provide precision medicine to all patients across a vast rural area. She has been integral to Sanford Healths effort to implement and expand pharmacogenomics into primary care. She serves as Professor of Internal Medicine for the University of South Dakota College of Medicine in 2018. April received her certification of clinical application of pharmacogenomics in 2018 from the University of Florida and serves as a member of the Clinical Pharmacogenomics Implementation Consortium.
Mary Relling, St. Jude
Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.